Affiliation:
1. Keio University School of Medicine
Abstract
Abstract
Background: Maintaining remission after electroconvulsive therapy (ECT) is clinically relevant in patients with depression, and maintenance ECT has been introduced in patients who fail to maintain remission after ECT. However, the clinical characteristics and biological background of patients who receive maintenance ECT are poorly understood. Thus, this study aimed to examine the clinical background of patients who underwent maintenance ECT.
Methods: Patients with major depressive disorder who underwent ECT followed by maintenance ECT (mECT group) and those who did not (acute ECT [aECT] group) were included. Clinical characteristics, including the results of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter imaging single-photon emission computerized tomography (DaT) were compared between the groups.
Results: In total, 13 and 146 patients were included in the mECT and aECT groups, respectively. Compared to the aECT group, the mECT group showed a significantly higher prevalence of melancholic features (92.3% vs. 27.4%, p < 0.001) and catatonic features (46.2% vs. 9.6%, p = 0.002). Overall, 5/13 patients in the mECT group and 16/146 patients in the aECT group showed relevant imaging findings for Parkinson's disease and dementia with Lewy bodies (PD/DLB) on MIBG scintigraphy or DaT; the positive rate was not significantly different between the two groups.
Limitations: Neurological examinations for PD/DLB were not performed.
Conclusions: Patients who receive acute and maintenance ECT may have underlying neurodegenerative diseases, including PD/DLB. Investigating the neurobiology of patients who receive maintenance ECT is important for developing appropriate treatment for depression.
Publisher
Research Square Platform LLC
Reference35 articles.
1. Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy;Weiss A;Aust N Z J Psychiatry,2019
2. Estimating the true global burden of mental illness;Vigo D;The lancet Psychiatry,2016
3. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis;Cuijpers P;Acta Psychiatr Scand,2021
4. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression;Keller MB;N Engl J Med,2000
5. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression;Murphy GE;Arch Gen Psychiatry,1984